Interestingly, not only is this increase in IL-6 levels in plasma detectable in HD gene carriers 16 years prior to predicted onset of symptoms [92], but these levels also correlate well with clinical severity scores in pre-manifest and manifest HD gene carriers. The gene discussed is IL6; the disease is Huntington disease.